International Flavors & Fragrances (IFF) reported its Q4 and full-year 2025 earnings, emphasizing disciplined execution and strategic portfolio optimization. The company showed solid sales and EBITDA growth across most divisions, particularly Taste, Health & Biosciences, and Scent, while also making progress on divesting non-core assets like Pharma Solutions and launching the sale process for Food Ingredients. IFF provided a 2026 outlook expecting 1% to 4% comparable currency-neutral sales growth and 3% to 8% EBITDA growth, driven by innovation, productivity, and volume increases, despite continued macroeconomic uncertainty.
This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
International Flavors & Fragrances Inc. (NYSE:IFF) Q4 2025 Earnings Call Transcript
International Flavors & Fragrances (IFF) reported its Q4 and full-year 2025 earnings, emphasizing disciplined execution and strategic portfolio optimization. The company showed solid sales and EBITDA growth across most divisions, particularly Taste, Health & Biosciences, and Scent, while also making progress on divesting non-core assets like Pharma Solutions and launching the sale process for Food Ingredients. IFF provided a 2026 outlook expecting 1% to 4% comparable currency-neutral sales growth and 3% to 8% EBITDA growth, driven by innovation, productivity, and volume increases, despite continued macroeconomic uncertainty.